Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?

210
18
Favorite

Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?

kalkine media2022-02-28

HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

210

Report

Comment（18）

shwan
·2022-02-28
go
Reply
1
Report
Daviistoh
·2022-02-28
Go
Reply
4
Report
ZhiLing
·2022-02-28
ok
Reply
3
Report
Dinesh27
·2022-02-28
Pls like thank you
Reply
4
Report
kevinlaisq
·2022-02-28
Pls like
Reply
6
Report
Ah Deck
·2022-02-28
Pls like
Reply
4
Report
Roarhigher
·2022-02-28
Good
Reply
4
Report
TC93
·2022-02-28
Ok
Reply
4
Report
Wyyy___
·2022-02-28
Good
Reply
4
Report
JonC1997
·2022-02-28
Hello
Reply
5
Report
kel0508
·2022-02-28
Like pls
Reply
2
Report
rayjs
·2022-02-28
Aaaa
Reply
3
Report
Huntsilencer
·2022-02-28
Up
Reply
3
Report
mwlnairda
·2022-02-28
K
Reply
7
Report
xsamuraix
·2022-02-28
yes
Reply
6
Report
sk27
·2022-02-28
great
Reply
6
Report
Jliang
·2022-02-28
Please like
Reply
5
Report
T0000024852
·2022-02-28
Hi
Reply
6
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1125124592?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-02-28 11:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125124592","market":"other","top_or_hot":-1,"title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","media":"kalkine media","content":"<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Source Link</a>\n\n</div>\n","source":"lsy1642396333099","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRT.AU","symbol_name":"Virtus Health","start_time":0,"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","article_id":"1125124592","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","pubTimestamp":1646018948,"sourceInfo":{"source_id":"lsy1642396333099","name":"kalkinemedia"},"weMediaInfo":null,"summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","collect":0,"end_time":0,"defaultTopTitle":"kalkinemedia.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"VRT.AU":"Virtus Health"},"translate_title":"为什么Virtus（ASX：VRT）的股票今天会受到投资者的关注？","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRT.AU":0.9},"content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9039648134,"gmtCreate":1646032008540,"gmtModify":1676534083936,"author":{"id":"3561072096203079","authorId":"3561072096203079","name":"shwan","avatar":"https://static.tigerbbs.com/fb6398d4509a4b0dab2e079bf75c0660","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3561072096203079","authorIdStr":"3561072096203079"},"htmlText":"go","listText":"go","text":"go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039648134","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039656755,"gmtCreate":1646028006682,"gmtModify":1676534083753,"author":{"id":"3576615106113162","authorId":"3576615106113162","name":"Daviistoh","avatar":"https://static.tigerbbs.com/5fa47c53322f21d8995790f695aa8e1c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3576615106113162","authorIdStr":"3576615106113162"},"htmlText":"Go","listText":"Go","text":"Go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039656755","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039653285,"gmtCreate":1646027089165,"gmtModify":1676534083615,"author":{"id":"3557823792637532","authorId":"3557823792637532","name":"ZhiLing","avatar":"https://static.tigerbbs.com/40d052b9f7db59b50f72a3cbcbc99234","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3557823792637532","authorIdStr":"3557823792637532"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039653285","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039627080,"gmtCreate":1646025841668,"gmtModify":1676534083548,"author":{"id":"3557040767939621","authorId":"3557040767939621","name":"Dinesh27","avatar":"https://static.tigerbbs.com/01dd12a5a0a5ed6a1d858724f8f07d38","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3557040767939621","authorIdStr":"3557040767939621"},"htmlText":"Pls like thank you","listText":"Pls like thank you","text":"Pls like thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039627080","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039622206,"gmtCreate":1646025093605,"gmtModify":1676534083494,"author":{"id":"3572874548548490","authorId":"3572874548548490","name":"kevinlaisq","avatar":"https://static.tigerbbs.com/329de1199f764a89b7cadf50308e183d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3572874548548490","authorIdStr":"3572874548548490"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039622206","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039626906,"gmtCreate":1646024698922,"gmtModify":1676534083447,"author":{"id":"4098445225447010","authorId":"4098445225447010","name":"Ah Deck","avatar":"https://static.tigerbbs.com/0e52eb1e14e0f630d24f1687ea546cd8","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"4098445225447010","authorIdStr":"4098445225447010"},"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039626906","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039629244,"gmtCreate":1646023728707,"gmtModify":1676534083367,"author":{"id":"3555104076236141","authorId":"3555104076236141","name":"Roarhigher","avatar":"https://static.tigerbbs.com/80741e96f295312c1997c6a41bb6ea13","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3555104076236141","authorIdStr":"3555104076236141"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039629244","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039620173,"gmtCreate":1646023411804,"gmtModify":1676534083343,"author":{"id":"3582232015540876","authorId":"3582232015540876","name":"TC93","avatar":"https://static.tigerbbs.com/6a18b473e3eeffa8d209febc34817e5b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582232015540876","authorIdStr":"3582232015540876"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039620173","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039664577,"gmtCreate":1646022954950,"gmtModify":1676534083304,"author":{"id":"3574080073947891","authorId":"3574080073947891","name":"Wyyy___","avatar":"https://static.tigerbbs.com/64b7dd0feb90ece741c35cbd80d7b9c8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574080073947891","authorIdStr":"3574080073947891"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039664577","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039666785,"gmtCreate":1646022385862,"gmtModify":1676534083240,"author":{"id":"3581841381174598","authorId":"3581841381174598","name":"JonC1997","avatar":"https://static.tigerbbs.com/3b36205562e7be603067005666045365","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581841381174598","authorIdStr":"3581841381174598"},"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039666785","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039666529,"gmtCreate":1646022347473,"gmtModify":1676534083224,"author":{"id":"3581934736299674","authorId":"3581934736299674","name":"kel0508","avatar":"https://static.tigerbbs.com/893b8204be964dc6d17ba74e699e3c2a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581934736299674","authorIdStr":"3581934736299674"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039666529","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039663718,"gmtCreate":1646021782635,"gmtModify":1676534083177,"author":{"id":"3582194391985550","authorId":"3582194391985550","name":"rayjs","avatar":"https://static.tigerbbs.com/c7c5a87eb80a4d23caa89490493c51fd","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582194391985550","authorIdStr":"3582194391985550"},"htmlText":"Aaaa","listText":"Aaaa","text":"Aaaa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039663718","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039684772,"gmtCreate":1646020718400,"gmtModify":1676534083082,"author":{"id":"3583029437333652","authorId":"3583029437333652","name":"Huntsilencer","avatar":"https://static.tigerbbs.com/9b69d6b5db7ba7ec92be9ac8c5c5705c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3583029437333652","authorIdStr":"3583029437333652"},"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039684772","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039686401,"gmtCreate":1646020091835,"gmtModify":1676534082946,"author":{"id":"3567423611057591","authorId":"3567423611057591","name":"mwlnairda","avatar":"https://static.tigerbbs.com/98729f78c147e999683a15cff1ffbc62","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":3,"crmLevelSwitch":0,"idStr":"3567423611057591","authorIdStr":"3567423611057591"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039686401","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039686563,"gmtCreate":1646020079617,"gmtModify":1676534082947,"author":{"id":"3586859221825446","authorId":"3586859221825446","name":"xsamuraix","avatar":"https://static.tigerbbs.com/a273615536345cba34cf720fc60d9a06","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586859221825446","authorIdStr":"3586859221825446"},"htmlText":"yes&nbsp;","listText":"yes&nbsp;","text":"yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039686563","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039688285,"gmtCreate":1646019827337,"gmtModify":1676534082923,"author":{"id":"3582018187984085","authorId":"3582018187984085","name":"sk27","avatar":"https://community-static.tradeup.com/news/9eff7bdabcd1448e80d9f4881925e9bb","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3582018187984085","authorIdStr":"3582018187984085"},"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039688285","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039688305,"gmtCreate":1646019794770,"gmtModify":1676534082910,"author":{"id":"3578105588635717","authorId":"3578105588635717","name":"Jliang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578105588635717","authorIdStr":"3578105588635717"},"htmlText":"Please like&nbsp;","listText":"Please like&nbsp;","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039688305","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9039681966,"gmtCreate":1646019522869,"gmtModify":1676534082884,"author":{"id":"3586426272011868","authorId":"3586426272011868","name":"T0000024852","avatar":"https://static.tigerbbs.com/558c2124ff14f2c3586c97422ed4a346","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586426272011868","authorIdStr":"3586426272011868"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9039681966","repostId":1125124592,"repostType":4,"repost":{"id":"1125124592","pubTimestamp":1646018948,"share":"https://ttm.financial/m/news/1125124592?lang=&edition=fundamental","pubTime":"2022-02-28 11:29","market":"other","language":"en","title":"Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125124592","media":"kalkine media","summary":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest","content":"<html><head></head><body><p>Highlights</p><ul><li>Virtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.</li><li>The proposal concerns acquisition of 100% of VRT shares.</li><li>VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.</li></ul><p>Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.</p><p>At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).</p><p>BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.</p><p>The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.</p><p>Virtus also informed today that the implementation of the Revised Proposal is conditional.</p><p><b><i>Other details of the revised proposal:</i></b></p><p>BGH has advised that its entry into the SIA will be subject to the following:</p><ul><li>The satisfactory completion of due diligence</li><li>After today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;</li><li>No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;</li><li>Final approval to submit a binding proposal from the BGH Investment Committee</li></ul><p>BGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.</p><p><b><i>BGH’s old proposal:</i></b></p><p>On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.</p><p><b><i>Company’s interim results for the half-year ended 31 December 2021:</i></b></p><p>The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.</p><p>The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.</p><p><img src=\"https://static.tigerbbs.com/8e327baa60bba9dbc47479d5ef087727\" tg-width=\"750\" tg-height=\"452\" width=\"100%\" height=\"auto\"/><b><i>Proposal from CapVest:</i></b></p><p>In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.</p></body></html>","source":"lsy1642396333099","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why are Virtus (ASX:VRT) Shares on Investors’ Radar Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy are Virtus (ASX:VRT) Shares on Investors’ Radar Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-28 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today><strong>kalkine media</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were ...</p>\n\n<a href=\"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRT.AU":"Virtus Health"},"source_url":"https://kalkinemedia.com/au/stocks/healthcare/why-are-virtus-asxvrt-shares-on-investors-radar-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125124592","content_text":"HighlightsVirtus Health Limited has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd.The proposal concerns acquisition of 100% of VRT shares.VRT stocks were spotted trading 3.310% higher at AU$7.490 per share on ASX at 12:57 PM AEDT.Shares of Virtus Health Limited (ASX:VRT) were in focus on Monday (28 February 2022) after the assisted reproductive services company revealed that it has received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd (“BGH”). The updated proposal is concerning the acquisition of all of Virtus’ shares by way of a scheme of arrangement at AU$7.65 cash per share, less the value of any dividends or other distributions declared, proposed or paid post the date of this letter, including the A$0.12 per share dividend declared by Virtus on 22 February 2022.At AU$7.490 per share, the share price of Virtus Health Limited has gained 21.99% in the past 12 months. In this year so far, Virtus’ shares are 10.96% higher on Year-to-date (YTD).BGH’s Revised Proposal is conditional on Virtus and BGH signing an Engagement Deed, which incorporates specific discrete provisions from the current CapVest Process Deed, which was released to ASX on 24 February 2022, in the same form but with select necessary modifications.The private equity company BGH intends to fund the acquisition through equity and debt financing. As per today’s announcement, the equity financing will come from BGH Fund I, and BGH advises that they have received highly confident debt financing letters from several institutions to support a binding proposal.Virtus also informed today that the implementation of the Revised Proposal is conditional.Other details of the revised proposal:BGH has advised that its entry into the SIA will be subject to the following:The satisfactory completion of due diligenceAfter today’s date (28 February 2022), Virtus does not sell or agree to sell any material assets or enter into or agree to enter into any joint venture or similar arrangements concerning any of Virtus’ domestic or international operations;No material change to Virtus’ assets and prospects (including litigation or regulatory action arising), or financial markets;Final approval to submit a binding proposal from the BGH Investment CommitteeBGH noted that it has already applied for a no-objection notice from the Foreign Investment Review Board to acquire 100% of the shares in Virtus and expects to receive it soon.  The company has said that the Board is yet to evaluate the revised proposal.BGH’s old proposal:On 14 December 2021, Virtus had informed that it received an unsolicited, non-binding indication of interest from BGH Capital to acquire 100% of the issued, and to be issued, shares of Virtus by way of a scheme of arrangement. The proposal attributed a cash value of AU$7.10 cash per Virtus share, valuing the target at approximately AU$607 million.Company’s interim results for the half-year ended 31 December 2021:The company has declared an interim dividend of 12.0 cents per share fully franked. The interim dividend will be payable on 14 April 2022. The Group has reported its revenue at AU$171.3 million compared to AU$169.6 million in H1FY21.The reported EBITDA declined 35.7% to AU$37.9 million from AU$59 million in H1 FY22.Proposal from CapVest:In an announcement dated 20 January 2022, Virtus Health advised that it has received a proposal from CapVest Partners LLP (“CapVest”) to acquire 100% of Virtus through a scheme of arrangement offering AU$7.60 cash per share.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":210,"commentSize":18,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}